PCI Versus Conservative Management Before TAVR in Patients With Significant Coronary Artery Disease: A Nationwide Instrumental Variable Analysis
Circulation: Cardiovascular Interventions · 2026-04 · 19 (4)
DOI: 10.1161/circinterventions.125.016337 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Circulation: Cardiovascular Interventions, 2026-04. Verfasst von Antros Louca und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology (A.L., P.P., J.S., K.S., M.M., D.I., S.V., A.M., O.A., A. Rawshani, T.R.), Sahlgrenska University Hospital, Gothenburg, Swed…. Hauptthemen laut MEDLINE: Conservative Treatment, Percutaneous Coronary Intervention, Transcatheter Aortic Valve Replacement, Coronary Artery Disease. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 41 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: The optimal management of coronary artery disease in patients undergoing transcatheter aortic valve replacement (TAVR) remains unclear, and evidence supporting routine percutaneous coronary intervention (PCI) beforehand is limited. This study aimed to evaluate whether PCI before TAVR provides clinical benefit compared with conservative management in patients with significant coronary artery disease, using nationwide Swedish registry data. METHODS: This observational study included 2578 Swedish patients with significant coronary artery disease (≥50% angiographic stenosis or physiologically significant lesions) who underwent TAVR between 2008 and 2023. 1182 underwent PCI before TAVR, and 1396 were managed conservatively. The primary outcome was a composite of all-cause mortality, myocardial infarction, and urgent revascularization. Secondary outcomes included the individual components, cardiovascular mortality, any revascularization, stroke, and bleeding. The primary analysis used an instrumental variable approach based on each region’s quarterly PCI treatment preference to account for confounding. RESULTS: PCI was not associated with a significant difference in the primary composite outcome (instrumental variable–adjusted hazard ratio, 0.98 [95% CI, 0.85–1.14]; P =0.80) or in all-cause mortality, myocardial infarction, cardiovascular death, stroke, or urgent revascularization. PCI was, however, associated with a lower risk of any revascularization (adjusted hazard ratio, 0.46 [95% CI, 0.30–0.72]; adjusted P =0.002) and a higher risk of bleeding (instrumental variable–adjusted odds ratio, 1.59 [95% CI, 1.23–2.04]; adjusted P =0.002). CONCLUSIONS: In this nationwide cohort, PCI before TAVR did not improve survival or reduce urgent revascularization but did reduce nonurgent revascularization at the cost of increased bleeding. Decisions should be individualized, balancing ischemic and bleeding risks and considering anticipated coronary access after TAVR.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology (A.L., P.P., J.S., K.S., M.M., D.I., S.V., A.M., O.A., A. Rawshani, T.R.), Sahlgrenska University Hospital, Gothenburg, Sweden.
- Department of Molecular and Clinical Medicine, Institute of Medicine, University of Gothenburg, Sweden (A.L., P.P., J.S., K.S., M.M., A.J., D.I., S.V., A.M., O.A., A. Rawshani, T.R.).
- Heart Centre, Umeå University Hospital, Sweden (H.H.).
- Department of Public Health and Clinical Medicine, Umeå University, Sweden (H.H.).
- Department of Cardiology, Karolinska University Hospital and Karolinska Institute, Stockholm, Sweden (A. Rück).
- Department of Medical Sciences, Cardiology, Uppsala University, Sweden (S.J.).
ORCID-Profile: Antros Louca, Petur Petursson, Joakim Sundström, Andreas Rück, Stefan James, Kristofer Skoglund, Mohammed Mohammed, Anders Jeppsson, Dan Ioanes, Sebastian Völz, Anna Myredal, Oskar Angerås
Zitieren
APA
Louca, A., Petursson, P., Sundström, J., Hagström, H., Rück, A., James, S., Koul, S., Skoglund, K., Mohammed, M., Jeppsson, A., Ioanes, D., Völz, S., Myredal, A., Angerås, O., Rawshani, A., & Råmunddal, T. (2026). PCI Versus Conservative Management Before TAVR in Patients With Significant Coronary Artery Disease: A Nationwide Instrumental Variable Analysis. Circulation: Cardiovascular Interventions, 19(4). https://doi.org/10.1161/circinterventions.125.016337
Vancouver
Louca A, Petursson P, Sundström J, Hagström H, Rück A, James S, et al. PCI Versus Conservative Management Before TAVR in Patients With Significant Coronary Artery Disease: A Nationwide Instrumental Variable Analysis. Circulation: Cardiovascular Interventions. 2026;19(4). doi:10.1161/circinterventions.125.016337
BibTeX
@article{Louca2026,
author = {Louca, Antros and Petursson, Petur and Sundström, Joakim and Hagström, Henrik and Rück, Andreas and James, Stefan and Koul, Sasha and Skoglund, Kristofer and Mohammed, Mohammed and Jeppsson, Anders and Ioanes, Dan and Völz, Sebastian and Myredal, Anna and Angerås, Oskar and Rawshani, Araz and Råmunddal, Truls},
title = {PCI Versus Conservative Management Before TAVR in Patients With Significant Coronary Artery Disease: A Nationwide Instrumental Variable Analysis},
journal = {Circulation: Cardiovascular Interventions},
year = {2026},
volume = {19},
number = {4},
doi = {10.1161/circinterventions.125.016337}
}
EUVIMED